Paushak Limited (NSE:PAUSHAKLTD)
India · Delayed Price · Currency is INR 734.05
-20.25 (-2.68%)
At close: Sep 10, 2026
Paushak Revenue
Paushak had revenue of 835.40M INR in the quarter ending June 30, 2026, with 49.47% growth. This brings the company's revenue in the last twelve months to 2.46B, up 14.63% year-over-year. In the fiscal year ending March 31, 2026, Paushak had annual revenue of 2.19B with 3.63% growth.
Revenue (ttm)
2.46B
Revenue Growth
+14.63%
P/S Ratio
7.34
Revenue / Employee
6.71M
Employees
367
Market Cap
18.07B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.19B | 76.52M | 3.63% |
| Mar 31, 2025 | 2.11B | 46.89M | 2.27% |
| Mar 31, 2024 | 2.06B | -60.85M | -2.87% |
| Mar 31, 2023 | 2.12B | 622.44M | 41.47% |
| Mar 31, 2022 | 1.50B | 91.02M | 6.46% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossari Biotech | 25.50B |
| S H Kelkar and Company | 24.49B |
| Veedol Corporation | 22.63B |
| Jubilant Agri and Consumer Products | 19.72B |
| NOCIL | 13.70B |
| Shree Pushkar Chemicals & Fertilisers | 10.02B |
| Advanced Enzyme Technologies | 7.50B |
| Jai Corp | 6.07B |
Paushak News
- 5 months ago - India opens anti-dumping probe into ethyl chloroformate imports from China - The Times of India